Advisory Board Members

  Peter has had a successful career as a strategy consultant in the Life Science industry over the past 25 years. He has worked for several tier one strategy firms in the US and Europe. With extensive industry experience in pharma, biotech and medical diagnostics, he is a widely recognized authority in the industry on commercial trade channel management.

Peter holds a combined BE and ME (Dipl. Ing.) from RWTH-Aachen in mechanical engineering. Fluent in German, English and French.

Ghassan K Abou-Alfa* joined the Gastrointestinal Oncology Service at Memorial Sloan-Kettering Cancer Center and Weill Cornell Medical College in New York back in 2001. Dr Abou-Alfa specializes in the treatment of gastrointestinal malignancies. Dr Abou-Alfa received his medical degree from the American University of Beirut, Lebanon, and completed his post-doctoral training at Yale University School of Medicine. His research is dedicated to finding novel therapies and improving the effectiveness of the current therapies for hepatocellular carcinoma, cholangiocarcinoma and gallbladder cancer, while continuing to understand the basic mechanisms of the diseases and its therapy.

*Dr. Abou-Alfa is serving in a personal capacity

  Christian Holmer has extensive, diverse leadership experience in international operations, global strategy, global marketing, market access, business development, and financial management. He partners with corporate leadership teams to advance business, drive growth, and position companies for competitive success. Having led multiple organizations and teams through organic growth, partnerships, and reorganizations, Christian is an expert in quickly scaling businesses, strengthening service offerings, and driving margin growth across markets. As a member of several boards and steering committees, he has also helped evolve the general business environment in multiple countries such as Russia and Turkey through his partnership with industry associations and the American Chamber of Commerce.